ATE512230T1 - Proteinherstellungsverfahren unter nutzung von yebf - Google Patents

Proteinherstellungsverfahren unter nutzung von yebf

Info

Publication number
ATE512230T1
ATE512230T1 AT05774845T AT05774845T ATE512230T1 AT E512230 T1 ATE512230 T1 AT E512230T1 AT 05774845 T AT05774845 T AT 05774845T AT 05774845 T AT05774845 T AT 05774845T AT E512230 T1 ATE512230 T1 AT E512230T1
Authority
AT
Austria
Prior art keywords
protein
fusion protein
yebf
polypeptide
further comprise
Prior art date
Application number
AT05774845T
Other languages
English (en)
Inventor
Joel Weiner
Guijin Zhang
Original Assignee
Univ Alberta
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Alberta filed Critical Univ Alberta
Application granted granted Critical
Publication of ATE512230T1 publication Critical patent/ATE512230T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/24—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
    • C07K14/245—Escherichia (G)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/70—Vectors or expression systems specially adapted for E. coli
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/036—Fusion polypeptide containing a localisation/targetting motif targeting to the medium outside of the cell, e.g. type III secretion

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AT05774845T 2004-08-18 2005-08-12 Proteinherstellungsverfahren unter nutzung von yebf ATE512230T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US52212504P 2004-08-18 2004-08-18
PCT/CA2005/001249 WO2006017929A1 (en) 2004-08-18 2005-08-12 Protein production method utilizing yebf

Publications (1)

Publication Number Publication Date
ATE512230T1 true ATE512230T1 (de) 2011-06-15

Family

ID=35907194

Family Applications (1)

Application Number Title Priority Date Filing Date
AT05774845T ATE512230T1 (de) 2004-08-18 2005-08-12 Proteinherstellungsverfahren unter nutzung von yebf

Country Status (7)

Country Link
US (1) US20060246539A1 (de)
EP (1) EP1791961B1 (de)
JP (1) JP2008509682A (de)
AT (1) ATE512230T1 (de)
AU (1) AU2005274628A1 (de)
CA (1) CA2576083A1 (de)
WO (1) WO2006017929A1 (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102006050332A1 (de) 2006-10-25 2008-04-30 Wacker Chemie Ag DNS-Konstrukt und Verfahren zur fermentativen Herstellung von Fusionsproteinen
RU2632651C2 (ru) 2011-05-11 2017-10-06 Чилдрен'С Медикал Сентер Корпорейшн Модифицированный биотин-связывающий белок, слитые белки на его основе и их применение
AU2014214844B2 (en) 2013-02-07 2017-12-14 Children's Medical Center Corporation Protein antigens that provide protection against pneumococcal colonization and/or disease
US9616114B1 (en) 2014-09-18 2017-04-11 David Gordon Bermudes Modified bacteria having improved pharmacokinetics and tumor colonization enhancing antitumor activity
US10435697B2 (en) * 2014-11-03 2019-10-08 Nanyang Technological University Recombinant expression system that senses pathogenic microorganisms
WO2017087827A1 (en) * 2015-11-19 2017-05-26 President And Fellows Of Harvard College Method of making recombinant silk andsilk-amyloid hybrid proteins using bacteria
US11180535B1 (en) 2016-12-07 2021-11-23 David Gordon Bermudes Saccharide binding, tumor penetration, and cytotoxic antitumor chimeric peptides from therapeutic bacteria
WO2018183475A1 (en) 2017-03-28 2018-10-04 Children's Medical Center Corporation A multiple antigen presenting system (maps)-based staphylococcus aureus vaccine, immunogenic composition, and uses thereof
SG11201912601RA (en) 2017-06-23 2020-01-30 Nosocomial Vaccine Corp Immunogenic compositions
SG11202102007UA (en) 2018-09-12 2021-03-30 Affinivax Inc Multivalent pneumococcal vaccines
CA3126796A1 (en) * 2019-02-15 2020-08-20 Oncosimis Biotech Private Limited A bacterial expression vector for enhanced protein secretion
WO2020170228A1 (en) 2019-02-24 2020-08-27 Oncosimis Biotech Private Limited Method for continous production of recombinant glp-1 peptide by bacteria
US11471497B1 (en) 2019-03-13 2022-10-18 David Gordon Bermudes Copper chelation therapeutics
US10973908B1 (en) 2020-05-14 2021-04-13 David Gordon Bermudes Expression of SARS-CoV-2 spike protein receptor binding domain in attenuated salmonella as a vaccine

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1335357C (en) * 1987-10-30 1995-04-25 Timothy M. Rose Expression systems for preparation of polypeptides in prokaryotic cells
US5646016A (en) * 1991-02-06 1997-07-08 Genetics Institute, Inc. Peptide and protein fusions to thioredoxin, thioredoxin-like molecules, and modified thioredoxin-like molecules
US6033877A (en) * 1995-11-02 2000-03-07 Research Foundation Of State University Of New York Peptide expression and delivery system
US6022952A (en) * 1998-04-01 2000-02-08 University Of Alberta Compositions and methods for protein secretion
US6733997B1 (en) * 1998-10-30 2004-05-11 National University Of Singapore Isolated nucleic acids encoding a secretory signal for expression and secretion of heterologous recombinant proteins
FI109361B (fi) 1999-05-04 2002-07-15 Korpela Timo Mikrobinen proteiinin ilmentämisjärjestelmä
EP1409709A2 (de) * 2000-05-03 2004-04-21 Expressive Constructs, Inc. Verfahren zur verbesserung der protein-stabilität und -löslichkeit
EP1343870A4 (de) * 2000-11-09 2005-07-13 Univ Queensland Bakterielle expressionssysteme
US20040142429A1 (en) * 2001-01-25 2004-07-22 Grant Chris W.M. Method for the expression, purification, and structure recovery and handling of hydrophobic proteins, polypeptides or peptides
CA2445049A1 (en) * 2001-05-04 2002-11-14 Cornell Research Foundation, Inc. Rapidly cleavable sumo fusion protein expression system for difficult to express proteins
KR100447530B1 (ko) * 2001-08-14 2004-09-08 한국과학기술원 ＯｍｐＦ를 이용하여 목적 단백질을 대장균 세포외로분비생산하는 방법
US6790051B1 (en) * 2003-12-20 2004-09-14 Lear Corporation Connector for printed circuit board

Also Published As

Publication number Publication date
CA2576083A1 (en) 2006-02-23
EP1791961A1 (de) 2007-06-06
AU2005274628A1 (en) 2006-02-23
EP1791961A4 (de) 2008-11-19
US20060246539A1 (en) 2006-11-02
EP1791961B1 (de) 2011-06-08
WO2006017929A1 (en) 2006-02-23
JP2008509682A (ja) 2008-04-03

Similar Documents

Publication Publication Date Title
ATE512230T1 (de) Proteinherstellungsverfahren unter nutzung von yebf
SG161210A1 (en) Methods for expression and purification of recombinant human growth hormone
AR110864A2 (es) Procesos para cultivos celulares
PE20110310A1 (es) Axmi-115, axmi-113, axmi-005, axmi-163 y axmi-184: proteinas insecticidas
DE602006018587D1 (de) Verfahren zur verbesserten isolierung rekombinant produzierter proteine
DK1422237T3 (da) Fremgangsmåder til rekombinant frembringelse af antifusogene peptider
ATE408016T1 (de) Verfahren zur herstellung und sekretion modifizierter peptide
WO2002099067A3 (en) Gene expression and production of tgf-b proteins including bioactive mullerian inhibiting substance from plants
JP2008509682A5 (de)
ATE426674T1 (de) Stoffwechselanderungen in garungen zur produktion rekombinanter proteine
DK1905839T3 (da) Fremgangsmåde til fermentativ fremstilling af proteiner
ATE326523T1 (de) Verfahren zur fermentativen herstellung von l- methionin
WO2005026375A3 (en) Recombinant carrier molecule for expression, delivery and purification of target polypeptides
DE69906509D1 (de) Herstellung einzelner genprodukte eines chimären fusionsproteins durch spaltung mit überall vorkommenden endoproteasen
ATE298794T1 (de) Verfahren zur herstellung und reinigung von sekretierten proteinen und herstellung von protein-arrays
CN104195157A (zh) 生物活性肽在原核细胞中的高效率重组表达和纯化方法
ATE486935T1 (de) Mikroorganismenstamm zur produktion von rekombinanten proteinen
DE60029968D1 (de) Proteinherstellung
EA201000945A1 (ru) Конструирование системы секреции на основе sm-белков
DE60334109D1 (de) Yapsin-mangelmutantenstamm von hansenula polymorpha sowie verfahren zur herstellung rekombinanter proteine damit
DE60021404D1 (de) System zur herstellung von proteinen
MXPA05012336A (es) Procedimiento para producir una proteina dirigida a un plastidio en celulas vegetales.
WO2002002591A3 (en) Peptides for use in culture media
DE602005016847D1 (de) Nichtaktivierte polypeptide mit einer geweberegenerationsfunktion und verfahren zu ihrer herstellung
DE602004023408D1 (de) Agments unter verwendung einer e.coli-signalsequenz sowie verfahren zur massenproduktion des antikörperfragments

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties